As one of the individual-based medication for adverse effects induced by chemotherapy, UDP-glucuronosyltransferases (UGT) 1A1*28 has been suggested to be related to neutropenia induced by irinotecan, a topoisomerase inhibitor used in combination with other chemotherapeutic agents. The gene discussed is B3GAT2; the disease is neutropenia.